Skip to main content
. 2016 Oct 26;7(49):80262–80274. doi: 10.18632/oncotarget.12918

Figure 9. Andrographolide inhibited LPS and OVA triggered ROS generation.

Figure 9

A. Raw264.7 Cells were treated with various concentrations of Andrographolide in the absence or presence of 100 ng/ml LPS for 6 h. B. BMDM were treated with various concentrations of Andrographolide in the absence or presence of 40 μM OVA for 6 h. ROS level was examined by DCFH stain. *P < 0.05, **P < 0.01 vs. LPS or OVA-treated group.